Persistently elevated CKMB and negative troponin T in a patient at ischaemic risk with chest pain
D Schulenburg1, W De Lange, H Van Jaarsveld
1Department of Chemical Pathology, Universitas National Health Laboratory Services, University of the Free State, Bloemfontein, South Africa.
Insights
Macro-creatine kinase (macro-CK) can cause analytical interference in laboratory assays. This case highlights how macro-CK led to incongruent biochemical results in a patient with chest pain, potentially impacting diagnosis and treatment.
Area of Science:
- Clinical Biochemistry
- Laboratory Medicine
- Diagnostic Assays
Background:
- Analytical interference in laboratory testing is a significant clinical challenge.
- Unrecognized interferences can lead to patient misdiagnosis and inappropriate management.
- Creatine kinase MB (CKMB) activity assays are crucial for diagnosing myocardial infarction.
Observation:
- A patient presented with chest pain and ischemic risk factors.
- Incongruent biochemical results were observed during laboratory analysis.
- The presence of macro-creatine kinase (macro-CK) was identified as the cause.
Findings:
- Macro-CK, an in vivo complex of CK isoforms, interfered with the CKMB activity assay.
- This interference led to inaccurate CKMB measurements.
- The specific mechanism of interference was identified in this case.
Implications:
- Accurate laboratory diagnostics are essential for effective patient care.
- Awareness of macro-CK interference is critical for clinical laboratory scientists and physicians.
- This case underscores the need for robust analytical interference detection protocols in clinical laboratories.
Abstract:
Analytical interference in laboratory assays is not only unpredictable but also an underestimated problem. Not recognising these interferences can lead to misdiagnosis and mismanagement of patients. We present a case of a patient with chest pain and ischaemic risk factors with incongruent biochemical results. These results were discovered to be due to the presence of macro-creatine kinase (macro-CK) in vivo interfering with the CKMB activity assay.
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Angina II: Classification
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests

